Recent BioUtah News & Events

Blackrock Neurotech, the world’s leading platform for brain-computer interface (BCI) technology and manufacturing, has closed a $10 million financing round, led by Christian Angermayer’s re.Mind Capital with participation from Peter Thiel, German entrepreneur Tim Sievers, and Sorenson Impact’s University Venture Fund II. The funding will further expand programs on the Blackrock platform, including clinical studies […]

In last week’s BioUtah News and Events, we highlighted the Biden Administration’s formation of a task force to address a range of supply chain issues. This week, we share the findings of the administration’s 100-day assessment of critical supply chains, undertaken pursuant to President Biden’s February 2021 “America’s Supply Chains” executive order addressing supply chain […]

Founded in 1984, ARUP Laboratories, one of the nation’s largest reference laboratories, on Tuesday held a ribbon cutting ceremony to officially open its new four-story, 220,000-square-foot laboratory facility located in University of Utah Research Park. The newly constructed facility is the crown jewel of eight properties ARUP now owns and operates as Research Park’s largest […]

Elute has received an Investigational Device Exemption (IDE) authorization from the FDA to use its EP Granules with TobramycinTM in a pivotal clinical trial. This IDE investigates the use of a resorbable bone void filler that delivers a broad-spectrum antibiotic in the surgical treatment of bone infections following hip or knee replacements. This is the […]

RenalytixAI has announced a series of key hires to drive its commercialization strategy in the U.S. market in light of the recently announced Federal Government General Service Administration payment contract and additional large healthcare system partnerships. The combined background and experience of the new leadership team is expected to drive adoption of the KidneyIntelX testing […]

The St. George Chamber of Commerce recently held a special luncheon with a presentation by Travis Sheffield, operations director for Intermountain Precision Genomics on “How St. George Became the Epicenter for a Major Global Genetics Study”. Sheffield, who is leading the HerediGene Population Study throughout Utah, Idaho, and soon in Nevada, presented the ins and […]

On June 8, Altitude Lab has announced the launch of its Investor Coalition, a partnered network of leading healthcare venture capitalists to fund, mentor, and provide resources for Altitude-incubated startups. Together, the investor coalition aims to collectively invest $50 million in Altitude’s startups over the next three years, specifically supporting diverse and underrepresented founders. In […]

On Tuesday, the U.S. Senate passed the Endless Frontier Act to boost U.S. innovation and out-compete China. The bill passed the Senate by a vote of 68-32. The bill would provide $120 billion to the NSF, DOE and NASA to support research and develoopment in key technology areas critical to our national security, including biotechnology […]

Salt Lake City – BioUtah President and CEO, Kelvyn Cullimore, issued the following statement upon the launch of Altitude Lab’s Investor Coalition to fund and mentor life sciences startups in Utah. BioUtah President and CEO, Kelvyn Cullimore, issued the following statement upon the launch of Altitude Lab’s Investor Coalition to fund and mentor life sciences […]

Scientia announced it has raised $50M in growth equity financing from Vivo Capital, a Palo Alto, CA-headquartered global healthcare investment firm. The financing will be used to accelerate sales, marketing, and new product development in both its core neurovascular stroke market as well as adjacent markets in peripheral vascular and interventional oncology. “We are excited […]

Utah has done it again! The 2021 “Rich States, Poor States” report recently released by the American Legislative Exchange Council (ALEC) ranks Utah as the state with the strongest economic outlook in the nation. Utah has held this first place designation for the past 14 years. View state-by-state data HERE. To determine its rankings, the […]

RenalytixA has announced results from a new utility study. The study confirms the importance of risk assessment testing in addressing treatment ambiguity in the early stages of diabetic kidney disease (DKD) and improving patient engagement and adherence – two major barriers to slowing or preventing DKD progression and preserving kidney health. In clinical studies, KidneyIntelX […]